IndiaTickerLatest filing: Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Investor Presentation
ObservedCompany dossier
Concord Biotech
NSE:CONCORDBIO · ISIN INE338H01029
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Concord Biotech
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹244.2 Cr · PAT ₹75.9 Cr.
Exchange XBRLLatest ownership: promoter group 44.08% and public 55.92% as of 30 Jun 2026.
Exchange XBRLLatest rating action: Concord Biotech Limited: Ratings reaffirmed
Archived reportMaterial events
Open timeline →What changed recently
Observed
Source filing Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE · investor presentation
Observed
Source filing Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · financial results
Observed
Source filing Concord Biotech Ltd - 543960 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
BSE · exchange filing
Observed
Source filing Concord Biotech Ltd - 543960 - Unaudited Standalone And Consolidated Financial Results For The First Quarter Ended On June 30, 2026
BSE · financial results
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹244.2 Cr
- Profit after tax
- ₹75.9 Cr
- EPS
- ₹7.26
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 44.08%
- Public
- 55.92%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL